In 2002 the Institute of Medicine (which is not part of the NIH, but is the health arm of the National Academy of Sciences) called for the creation of a National Vaccine Authority that would have sweeping responsibilities, including market research, the establishment of priorities, control of intellectual-property rights, the conduct of in-house research and development and the financing of clinical trials of candidate vaccines.
FORBES: Commentary